680 related articles for article (PubMed ID: 17848610)
41. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure.
Smets YF; Westendorp RG; van der Pijl JW; de Charro FT; Ringers J; de Fijter JW; Lemkes HH
Lancet; 1999 Jun; 353(9168):1915-9. PubMed ID: 10371569
[TBL] [Abstract][Full Text] [Related]
42. Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry.
Nishimura R; Dorman JS; Bosnyak Z; Tajima N; Becker DJ; Orchard TJ; ;
Am J Kidney Dis; 2003 Jul; 42(1):117-24. PubMed ID: 12830463
[TBL] [Abstract][Full Text] [Related]
43. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
[TBL] [Abstract][Full Text] [Related]
44. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
[TBL] [Abstract][Full Text] [Related]
45. Renal replacement therapy in rural and urban Australia.
Gray NA; Dent H; McDonald SP
Nephrol Dial Transplant; 2012 May; 27(5):2069-76. PubMed ID: 21984553
[TBL] [Abstract][Full Text] [Related]
46. Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia.
Comas J; Arcos E; Castell C; Cases A; Martínez-Castelao A; Doñate T; Esmatjes E
Nephrol Dial Transplant; 2013 May; 28(5):1191-8. PubMed ID: 23147160
[TBL] [Abstract][Full Text] [Related]
47. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
[TBL] [Abstract][Full Text] [Related]
48. Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry.
Brunner FP; Brynger H; Challah S; Fassbinder W; Geerlings W; Selwood NH; Tufveson G; Wing AJ
Nephrol Dial Transplant; 1988; 3(5):585-95. PubMed ID: 3146713
[TBL] [Abstract][Full Text] [Related]
49. Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence.
Couchoud C; Guihenneuc C; Bayer F; Lemaitre V; Brunet P; Stengel B;
Nephrol Dial Transplant; 2012 Jun; 27(6):2312-22. PubMed ID: 22121236
[TBL] [Abstract][Full Text] [Related]
50. Ethnic differences in the natural progression of nephropathy among diabetes patients in New Zealand: hospital admission rate for renal complications, and incidence of end-stage renal disease and renal death.
Joshy G; Dunn P; Fisher M; Lawrenson R
Diabetologia; 2009 Aug; 52(8):1474-8. PubMed ID: 19436991
[TBL] [Abstract][Full Text] [Related]
51. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.
Disney AP
Am J Kidney Dis; 1995 Jan; 25(1):165-75. PubMed ID: 7810521
[TBL] [Abstract][Full Text] [Related]
52. The timing of dialysis and kidney transplantation in type 1 diabetes.
Pavlakis M
Diabetes Obes Metab; 2012 Aug; 14(8):689-93. PubMed ID: 22239150
[TBL] [Abstract][Full Text] [Related]
53. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
Tofik R; Torffvit O; Rippe B; Bakoush O
Diabetes Res Clin Pract; 2012 Jan; 95(1):139-44. PubMed ID: 22078636
[TBL] [Abstract][Full Text] [Related]
54. UK Renal Registry 16th annual report: chapter 8 survival and cause of death of UK adult patients on renal replacement therapy in 2012: national and centre-specific analyses.
Pruthi R; Steenkamp R; Feest T
Nephron Clin Pract; 2013; 125(1-4):139-69. PubMed ID: 24662172
[TBL] [Abstract][Full Text] [Related]
55. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.
Brancati FL; Whelton PK; Randall BL; Neaton JD; Stamler J; Klag MJ
JAMA; 1997 Dec; 278(23):2069-74. PubMed ID: 9403420
[TBL] [Abstract][Full Text] [Related]
56. Risk factors and outcomes of new-onset diabetes after transplant: single-centre experience.
Al-Ghareeb SM; El-Agroudy AE; Al Arrayed SM; Al Arrayed A; Alhellow HA
Exp Clin Transplant; 2012 Oct; 10(5):458-65. PubMed ID: 22943190
[TBL] [Abstract][Full Text] [Related]
57. Kidney transplantation in type 2 diabetic patients: a matched survival analysis.
Rocha A; Malheiro J; Martins LS; Fonseca I; Dias L; Pedroso S; Almeida M; Henriques AC
Transplant Proc; 2013; 45(6):2141-6. PubMed ID: 23747181
[TBL] [Abstract][Full Text] [Related]
58. Nationwide survey of adolescents and young adults with end-stage kidney disease.
Ritchie AG; Clayton PA; Mackie FE; Kennedy SE
Nephrology (Carlton); 2012 Aug; 17(6):539-44. PubMed ID: 22489755
[TBL] [Abstract][Full Text] [Related]
59. End-stage kidney disease due to scleroderma--outcomes in 127 consecutive ANZDATA registry cases.
Siva B; McDonald SP; Hawley CM; Rosman JB; Brown FG; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
Nephrol Dial Transplant; 2011 Oct; 26(10):3165-71. PubMed ID: 21357212
[TBL] [Abstract][Full Text] [Related]
60. Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population-based study.
Monesi L; Baviera M; Marzona I; Avanzini F; Monesi G; Nobili A; Tettamanti M; Cortesi L; Riva E; Fortino I; Bortolotti A; Fontana G; Merlino L; Roncaglioni MC
Diabet Med; 2012 Mar; 29(3):385-92. PubMed ID: 21913971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
